The pivotal Phase 3 AD clinical trial of buntanetap ( NCT06709014) is currently recruiting patients across the United States ...

Researchers in Japan discovered that Parkinson’s patients diagnosed in their 80s are far more likely to show signs of amyloid buildup, a hallmark of Alzheimer’s, even without dementia symptoms. The ...

Now, new research by Penn State scientists has revealed this vital process may be governed by a previously unknown molecular ...

Researchers have identified a way to help the brain clear out proteins implicated in Parkinson's and Alzheimer's Disease.

Parkinson's and Alzheimer's diseases are the two most common neurodegenerative disorders, affecting millions of people worldwide. Published in the Journal of Neuroscience, new research from the ...

In Alzheimer's disease, for instance, inflammationdisruptsthe healthy functioning of the immune cells of the central nervous system. In Parkinson's disease, inflammatory proteins can lead to ...

Despite growing recognition of the importance of the peripheral immune system in neurodegenerative disease, little is known about how these blood cells change in Alzheimer’s and Parkinson’s diseases.

For decades, Alzheimer’s disease has been framed as a one‑way slide, a slow erasure of memory that medicine could at best delay. That narrative is starting to crack. A wave of lab discoveries, smarter ...

The latest announcement is out from Annovis Bio ( (ANVS) ).

News and commentary from the world of neurology and neuroscience ...

Parkinson's disease does more than cause tremor and trouble walking. It can also affect sleep, smell, digestion and even ...